vs
CSX Corporation（CSX）与丹纳赫（DHR）财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是CSX Corporation的1.7倍（$6.0B vs $3.5B），CSX Corporation净利率更高（23.2% vs 17.3%，领先5.9%），丹纳赫同比增速更快（3.7% vs 1.7%），丹纳赫自由现金流更多（$1.1B vs $793.0M），过去两年丹纳赫的营收复合增速更高（1.8% vs -3.0%）
CSX运输是美国一级货运铁路企业，业务覆盖美国东部区域及加拿大安大略省、魁北克省，运营铁路总里程约3.4万公里，隶属于总部位于佛罗里达州杰克逊维尔市的财富500强企业CSX Corporation，是其旗下核心子公司。
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
CSX vs DHR — 直观对比
营收规模更大
DHR
是对方的1.7倍
$3.5B
营收增速更快
DHR
高出1.9%
1.7%
净利率更高
CSX
高出5.9%
17.3%
自由现金流更多
DHR
多$292.0M
$793.0M
两年增速更快
DHR
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $6.0B |
| 净利润 | $807.0M | $1.0B |
| 毛利率 | — | 60.3% |
| 营业利润率 | 29.9% | 22.6% |
| 净利率 | 23.2% | 17.3% |
| 营收同比 | 1.7% | 3.7% |
| 净利润同比 | 401.2% | 7.9% |
| 每股收益（稀释后） | — | $1.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSXDHR
| Q1 26 | $3.5B | $6.0B | ||
| Q4 25 | $3.5B | $6.8B | ||
| Q3 25 | $3.6B | $6.1B | ||
| Q2 25 | $3.6B | $5.9B | ||
| Q1 25 | $3.4B | $5.7B | ||
| Q4 24 | $3.5B | $6.5B | ||
| Q3 24 | $3.6B | $5.8B | ||
| Q2 24 | $3.7B | $5.7B |
净利润CSXDHR
| Q1 26 | $807.0M | $1.0B | ||
| Q4 25 | $720.0M | $1.2B | ||
| Q3 25 | $694.0M | $908.0M | ||
| Q2 25 | $829.0M | $555.0M | ||
| Q1 25 | $646.0M | $954.0M | ||
| Q4 24 | $720.0M | $1.1B | ||
| Q3 24 | $894.0M | $818.0M | ||
| Q2 24 | $963.0M | $907.0M |
毛利率CSXDHR
| Q1 26 | — | 60.3% | ||
| Q4 25 | — | 58.0% | ||
| Q3 25 | — | 58.2% | ||
| Q2 25 | — | 59.3% | ||
| Q1 25 | — | 61.2% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 58.7% | ||
| Q2 24 | — | 59.7% |
营业利润率CSXDHR
| Q1 26 | 29.9% | 22.6% | ||
| Q4 25 | 31.6% | 22.0% | ||
| Q3 25 | 30.3% | 19.1% | ||
| Q2 25 | 35.9% | 12.8% | ||
| Q1 25 | 30.4% | 22.2% | ||
| Q4 24 | 30.8% | 21.8% | ||
| Q3 24 | 37.4% | 16.5% | ||
| Q2 24 | 39.1% | 20.3% |
净利率CSXDHR
| Q1 26 | 23.2% | 17.3% | ||
| Q4 25 | 20.5% | 17.5% | ||
| Q3 25 | 19.3% | 15.0% | ||
| Q2 25 | 23.2% | 9.3% | ||
| Q1 25 | 18.9% | 16.6% | ||
| Q4 24 | 20.3% | 16.6% | ||
| Q3 24 | 24.7% | 14.1% | ||
| Q2 24 | 26.0% | 15.8% |
每股收益（稀释后）CSXDHR
| Q1 26 | — | $1.45 | ||
| Q4 25 | $0.39 | $1.69 | ||
| Q3 25 | $0.37 | $1.27 | ||
| Q2 25 | $0.44 | $0.77 | ||
| Q1 25 | $0.34 | $1.32 | ||
| Q4 24 | $0.38 | $1.50 | ||
| Q3 24 | $0.46 | $1.12 | ||
| Q2 24 | $0.49 | $1.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | — |
| 总债务越低越好 | $18.9B | — |
| 股东权益账面价值 | $13.6B | — |
| 总资产 | $44.2B | — |
| 负债/权益比越低杠杆越低 | 1.39× | — |
8季度趋势，按日历期对齐
现金及短期投资CSXDHR
| Q1 26 | $1.1B | — | ||
| Q4 25 | $5.0M | — | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $6.0M | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $72.0M | — | ||
| Q3 24 | $12.0M | — | ||
| Q2 24 | $4.0M | — |
总债务CSXDHR
| Q1 26 | $18.9B | — | ||
| Q4 25 | $18.2B | $18.4B | ||
| Q3 25 | $18.6B | $16.9B | ||
| Q2 25 | $18.6B | $17.4B | ||
| Q1 25 | $18.5B | $16.5B | ||
| Q4 24 | $17.9B | $16.0B | ||
| Q3 24 | $18.5B | $17.5B | ||
| Q2 24 | $18.0B | $17.0B |
股东权益CSXDHR
| Q1 26 | $13.6B | — | ||
| Q4 25 | $13.2B | $52.5B | ||
| Q3 25 | $12.8B | $51.1B | ||
| Q2 25 | $12.4B | $52.3B | ||
| Q1 25 | $12.2B | $50.8B | ||
| Q4 24 | $12.5B | $49.5B | ||
| Q3 24 | $12.9B | $51.3B | ||
| Q2 24 | $12.6B | $49.9B |
总资产CSXDHR
| Q1 26 | $44.2B | — | ||
| Q4 25 | $43.7B | $83.5B | ||
| Q3 25 | $43.3B | $79.9B | ||
| Q2 25 | $42.9B | $81.6B | ||
| Q1 25 | $43.2B | $79.1B | ||
| Q4 24 | $42.8B | $77.5B | ||
| Q3 24 | $43.1B | $80.6B | ||
| Q2 24 | $42.4B | $78.6B |
负债/权益比CSXDHR
| Q1 26 | 1.39× | — | ||
| Q4 25 | 1.38× | 0.35× | ||
| Q3 25 | 1.45× | 0.33× | ||
| Q2 25 | 1.50× | 0.33× | ||
| Q1 25 | 1.52× | 0.32× | ||
| Q4 24 | 1.43× | 0.32× | ||
| Q3 24 | 1.43× | 0.34× | ||
| Q2 24 | 1.42× | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $793.0M | $1.1B |
| 自由现金流率自由现金流/营收 | 22.8% | 18.2% |
| 资本支出强度资本支出/营收 | — | 4.0% |
| 现金转化率经营现金流/净利润 | 1.58× | 1.28× |
| 过去12个月自由现金流最近4个季度 | $2.0B | $5.3B |
8季度趋势，按日历期对齐
经营现金流CSXDHR
| Q1 26 | $1.3B | $1.3B | ||
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.3B | $1.7B | ||
| Q2 25 | $635.0M | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.7B | $1.5B | ||
| Q2 24 | $1.1B | $1.4B |
自由现金流CSXDHR
| Q1 26 | $793.0M | $1.1B | ||
| Q4 25 | $709.0M | $1.7B | ||
| Q3 25 | $607.0M | $1.4B | ||
| Q2 25 | $-141.0M | $1.1B | ||
| Q1 25 | $536.0M | $1.1B | ||
| Q4 24 | $550.0M | $1.5B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $547.0M | $1.1B |
自由现金流率CSXDHR
| Q1 26 | 22.8% | 18.2% | ||
| Q4 25 | 20.2% | 25.5% | ||
| Q3 25 | 16.9% | 22.6% | ||
| Q2 25 | -3.9% | 18.4% | ||
| Q1 25 | 15.7% | 18.4% | ||
| Q4 24 | 15.5% | 23.0% | ||
| Q3 24 | 29.3% | 21.0% | ||
| Q2 24 | 14.8% | 19.7% |
资本支出强度CSXDHR
| Q1 26 | — | 4.0% | ||
| Q4 25 | 19.3% | 5.4% | ||
| Q3 25 | 20.4% | 4.8% | ||
| Q2 25 | 21.7% | 4.2% | ||
| Q1 25 | 21.0% | 4.3% | ||
| Q4 24 | 23.7% | 7.9% | ||
| Q3 24 | 17.3% | 5.1% | ||
| Q2 24 | 14.6% | 5.0% |
现金转化率CSXDHR
| Q1 26 | 1.58× | 1.28× | ||
| Q4 25 | 1.93× | 1.77× | ||
| Q3 25 | 1.93× | 1.83× | ||
| Q2 25 | 0.77× | 2.41× | ||
| Q1 25 | 1.94× | 1.36× | ||
| Q4 24 | 1.93× | 1.86× | ||
| Q3 24 | 1.89× | 1.85× | ||
| Q2 24 | 1.13× | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
